BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Article contentMISSISSAUGA, Ontario, April 15, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX), a profitable growth-stage specialty healthcare products company, is pleased to announce that it will be presenting at the upcoming 2026 Bloom Burton & Co.

Healthcare Investor Conference. The conference will be held in Toronto at the Metro Toronto Convention Centre (North Building) on Tuesday, April 21st and Wednesday, April 22nd, 2026. Mr. René Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent’s business and corporate activities on Tuesday, April 21st at 2:30pm EDT. Sign In or Create an AccountEmail AddressContinueor View more offersArticle contentArticle contentMr. Goehrum will also be available to meet with investors on a one-on-one basis during the conference. These one-on-one meetings can be requested by registered attendees through the conference portal online: https://www.bloomburton.com/conference/.Article contentWe apologize, but this video has failed to load.Try refreshing your browser, ortap here to see other videos from our team.Article contentTop StoriesGet the latest headlines, breaking news and columns.There was an error, please provide a valid email address.Sign UpBy signing up you consent to receive the above newsletter from Postmedia Network Inc.Thanks for signing up!A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againInterested in more newsletters? Browse here.Article contentAbout BioSyent Inc.Article contentListed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent is a profitable growth-oriented specialty healthcare company focused on acquiring or in-licensing, marketing and distributing innovative pharmaceutical and oral health products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its Canadian pharma, international pharma, and oral health business units.Article contentAs of the date of this press release, the Company has 11,438,318 common shares outstanding.Article contentFor a direct market quote for the TSX Venture Exchange and other Company financial information please visit www.tmxmoney.com.Article contentArticle contentFor further information please contact:Article contentMr. René C. GoehrumPresident and CEOBioSyent Inc.E-Mail: investors@biosyent.comPhone: 905-206-0013Web: www.biosyent.comArticle contentThis press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be materially different from the forward-looking information or statements. Potential risks may include, but are not limited to, those associated with clinical trials, product development, future revenue, operations, profitability and obtaining regulatory approvals.Article contentNeither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.Article contentArticle contentArticle contentArticle contentArticle contentArticle contentTrending Trump Isolation Deepens on World Stage as Allies Rebuff, Condemn PMN Business The Great Correction: not even Wayne Gretzky's hometown could escape the crash of the 'exurbs' Real Estate Forcing people to pay a moral tax if they leave the country won't inspire them to stay Personal Finance Posthaste: What Mark Carney's gas tax cut could mean for the Bank of Canada News What is Anthropic's Mythos AI model and why does it have the financial world in a panic? Innovation Share this article in your social networkCommentsYou must be logged in to join the discussion or read more comments.Create an AccountSign in Join the Conversation Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information.

Trump Isolation Deepens on World Stage as Allies Rebuff, Condemn PMN Business The Great Correction: not even Wayne Gretzky's hometown could escape the crash of the 'exurbs' Real Estate Forcing people to pay a moral tax if they leave the country won't inspire them to stay Personal Finance Posthaste: What Mark Carney's gas tax cut could mean for the Bank of Canada News What is Anthropic's Mythos AI model and why does it have the financial world in a panic? Innovation